Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience.

Giuditta ChiloiroLuca BoldriniAngela RomanoLorenzo PlacidiHuong Elena TranMatteo NardiniMariangela MassaccesiFrancesco CelliniLuca IndovinaMaria Antonietta Gambacorta

Published in: La Radiologia medica (2023)

MRgSBRT was well tolerated by patients with reported low toxicity levels and a satisfying CB.

Keyphrases

magnetic resonance
radiation therapy
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
magnetic resonance imaging
peritoneal dialysis
squamous cell carcinoma
patient reported outcomes
rectal cancer
contrast enhanced
patient reported